A woman with plaque psoriasis on her elbow is sitting with her husband at the pool

Take on the
day with clearer
skin

Taltz is for adults and children 6 years and older with moderate to severe plaque psoriasis (PsO) who may benefit from taking injections or pills (systemic therapy) or treatment using ultraviolet or UV light (phototherapy).

First of its kind*

Taltz is the first treatment of its kind* that offers a chance at
100% clear skin.

Take a look at our before-and-after images to see how Taltz works on moderate to severe plaque psoriasis.

See visible skin results

*Interleukin-17A (IL-17A) antagonist that includes 100% clear skin in the Prescribing Information.

Select Important Safety Information

Taltz affects the immune system. It may increase your risk of infections, which can be serious. Do not use Taltz if you have any symptoms of infection, unless your doctor tells you to. If you have a symptom after starting Taltz, call your doctor right away.

TODO

How can Taltz help you with your symptoms?


Significant improvement

With Taltz, up to 90% of patients saw a significant improvement of their psoriasis plaques at 12 weeks. Four out of 10 achieved completely clear skin at 12 weeks.


Works quickly

Taltz works quickly to provide most patients significantly clearer skin by 12 weeks.


Stay clear

In patients who saw significant improvement in their psoriasis plaques at 12 weeks, most were still clearer at 5 years with continued therapy.

After completion of the initial clinical trial, additional data were collected in an extended, less-rigorous study.

Significant improvement

With Taltz, up to 90% of patients saw a significant improvement of their psoriasis plaques at 12 weeks. Four out of 10 achieved completely clear skin at 12 weeks.

Works quickly

Taltz works quickly to provide most patients significantly clearer skin by 12 weeks.

Stay clear

In patients who saw significant improvement in their psoriasis plaques at 12 weeks, most were still clearer at 5 years with continued therapy.

After completion of the initial clinical trial, additional data were collected in an extended, less-rigorous study.

Talk to your doctor about Taltz.

Select Important Safety Information

Your doctor should check you for tuberculosis (TB) before you start Taltz, and watch you closely for signs of TB during and after treatment with Taltz. If you have TB, or had it in the past, your doctor may treat you for it before you start Taltz.

TODO

Clearance in challenging body areas

In a clinical trial, the majority of patients with nail, scalp, and palm and sole psoriasis saw complete clearance of these areas at 5 years.

Nail psoriasis

64%


Patients had complete nail clearance

Scalp psoriasis

69%


Patients had complete scalp clearance

Palm and sole psoriasis

75%


Patients had complete palm and sole clearance

Nail psoriasis

64%


Patients had complete nail clearance

Scalp psoriasis

69%


Patients had complete scalp clearance

Palm and sole psoriasis

75%


Patients had complete palm and sole clearance

After completion of an initial clinical trial, additional data was collected in an extended, less rigorous study. These results are from a subset of patients from a moderate to severe plaque psoriasis clinical trial who also had nail, scalp, or palm and sole psoriasis. This was not the main purpose of the clinical trial.

Select Important Safety Information

Your doctor should check you for tuberculosis (TB) before you start Taltz, and watch you closely for signs of TB during and after treatment with Taltz. If you have TB, or had it in the past, your doctor may treat you for it before you start Taltz.

Taltz has helped real people with their plaque psoriasis symptoms.

Watch their stories
A man with plaque psoriasis on his elbow is eating lunch with his wife in a restaurant.

Actor portrayal.

Taltz vs Tremfya

In a clinical trial, more Taltz patients have shown complete skin clearance by 12 weeks.

A total of 41% of patients taking Taltz vs. 25% of patients taking Tremfya achieved complete skin clearance.

Tremfya is a registered trademark of Johnson & Johnson Corporation

Select Important Safety Information

Do not use Taltz if you have had a serious allergic reaction to ixekizumab or any other ingredient in Taltz, such as: swelling of your eyelids, lips, mouth, tongue or throat, trouble breathing, feeling faint, throat or chest tightness, or skin rash. Get emergency help right away if you have any of these reactions. See the Medication Guide that comes with Taltz for a list of ingredients.

Dig deeper

You've been dealing with your plague psoriasis for so long that you may feel like an expert. But there may still be more to learn about how to navigate your condition.

Learn more

Actor portrayal.

Person in kitchen opening a jar of flour

Find out how you can save on Taltz.

SAFETY SUMMARY

Warnings -

Taltz affects the immune system. It may increase your risk of infections, which can be serious. Do not use Taltz if you have any symptoms of infection, unless your doctor tells you to. If you have a symptom after starting Taltz, call your doctor right away.

Your doctor should check you for tuberculosis (TB) before you start Taltz, and watch you closely for signs of TB during and after treatment with Taltz. If you have TB, or had it in the past, your doctor may treat you for it before you start Taltz.

Do not use Taltz if you have had a serious allergic reaction to ixekizumab or any other ingredient in Taltz, such as: swelling of your eyelids, lips, mouth, tongue or throat, trouble breathing, feeling faint, throat or chest tightness, or skin rash. Get emergency help right away if you have any of these reactions. See the Medication Guide that comes with Taltz for a list of ingredients.

Crohn’s disease or ulcerative colitis (inflammatory bowel disease) can start or get worse with Taltz use. Tell your doctor if you have any of these symptoms or if they get worse: stomach pain, diarrhea, and weight loss.

You should not get live vaccines while taking Taltz. You should get the vaccines you need before you start Taltz.

Common side effects
The most common side effects of Taltz include:

  • Injection site reactions
  • Nausea
  • Upper respiratory infections
  • Fungal skin infections

Tell your doctor if you have any side effects. You can report side effects at 1-800-FDA-1088 or www.fda.gov/medwatch.

Before using

Before you use Taltz, review these questions with your doctor:

❑ Are you being treated for an infection?
❑ Do you have an infection that does not go away or keeps coming back?
❑ Do you have TB or have you been in close contact with someone with TB?
❑ Do you have possible symptoms of an infection such as fever, cough, sores, diarrhea, or other symptoms? Ask your doctor about other possible symptoms.
❑ Do you have Crohn’s disease or ulcerative colitis?

Tell your doctor if:

❑ You need any vaccines or have had one recently.
❑ You take prescription or over-the-counter medicines, vitamins, or herbal supplements.
❑ You are pregnant or planning to become pregnant. It is not known if Taltz can harm an unborn baby. Pregnancy Exposure Registry: There is a pregnancy registry to collect information about women who are exposed to Taltz during pregnancy. The purpose of this registry is to collect information about the health of you and your baby. If you become pregnant while taking Taltz, you are encouraged to enroll in the pregnancy registry by calling 1-800-284-1695 or by visiting online at https://www.taltz.com.
❑ You are breastfeeding or planning to breastfeed. It is not known if Taltz passes into breastmilk.

How to take

See the instructions for use that come with Taltz. There you will find information about how to store, prepare, and inject Taltz. Adults may self-inject after receiving training from a healthcare provider.

For people under 18 years of age:

  • Weighing less than 50 kg (i.e., 110 lb): Taltz must be given by a healthcare provider.
  • Weighing more than 50 kg (i.e., 110 lb): If your healthcare provider decides that your caregiver may give your injections of Taltz at home, your caregiver should ask and receive training from a healthcare provider on the right way to prepare and inject Taltz.

Learn more

Taltz is a prescription medicine. For more information, call 1-800-545-5979 or go to taltz.com.

This summary provides basic information about Taltz but does not include all information known about this medicine. Read the information that comes with your prescription each time your prescription is filled. This information does not take the place of talking with your doctor. Be sure to talk to your doctor or other healthcare provider about Taltz and how to take it. Your doctor is the best person to help you decide if Taltz is right for you.

IX CON BS 05OCT2022

Taltz® and its delivery device base are trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.

INDICATIONS

Taltz® (tȯl-ts) is an injectable medicine used to treat:

  • People 6 years of age and older with moderate to severe plaque psoriasis who may benefit from taking injections or pills (systemic therapy) or treatment using ultraviolet or UV light (phototherapy).
  • Adults with active psoriatic arthritis.
  • Adults with active ankylosing spondylitis.
  • Adults with active non-radiographic axial spondyloarthritis with objective signs of inflammation.

It is not known if Taltz is safe and effective in children for conditions other than plaque psoriasis or in children under 6 years of age.